RT Journal Article
T1 Validation of the eHealthResp online course for pharmacists and physicians: A Delphi method approach
A1 Estrela, Marta
A1 Roque, Fátima
A1 Silva, Tânia Magalhães
A1 Zapata Cachafeiro, Maruxa
A1 Figueiras Guzmán, Adolfo
A1 Herdeiro, Maria Teresa Ferreira
K1 E-Health
K1 Online course
K1 Delphi
K1 Content validation
K1 Respiratory tract infections
K1 Clinical cases
AB Framework: The inappropriate use of antibiotics for respiratory tract infections is dispersed worldwide, thus being a strong contributor to antibiotic resistances. As the use of educational interventions among health practitioners is shown to have an impact on judicious antibiotic use, an online course (eHealthResp) has been developed, especially targeted to pharmacists and physicians. Thus, the main goal of this study is to validate the contents of the online course eHealthResp.Methods: This two-round Delphi study involved the recruitment of a multidisciplinary panel (n = 19), to which the questionnaires of the first round were sent. After the first round, a report summing up the results has been forwarded to the panel, along with a new, reformulated version of the questionnaire.Results: After the two rounds of the Delphi process, consensus was evaluated. Six clinical cases and fifty-one treatments obtained minor consensus [60–75%] or full consensus (≥75%). The question on antibiotic practice has obtained a consensus >90% on both rounds.Conclusions:The validation of the contents based on experts’ consensus has been an essential approach to improve eHealthResp’s online course, as valuable feedback has been provided by the panel on both rounds
PB Elsevier
SN 0753-3322
YR 2021
FD 2021
LK http://hdl.handle.net/10347/26748
UL http://hdl.handle.net/10347/26748
LA eng
NO Biomedicine & Pharmacotherapy 2021, 40: 111739. https://doi.org/10.1016/j.biopha.2021.111739
NO Project PTDC/SAU-SER/31678/2017 was supported by the operational program of competitiveness and internationalisation, in its FEDER/FNR component POCI-01-0145-FEDER-031678, the Foundation for Science and Technology, in its state budget component (OE), and the Institute of Biomedicine (iBiMED) (UIDB/04501/2020 and POCI-01-0145-FEDER-007628)
DS Minerva
RD 24 abr 2026